- Home
- KNRX vs FBIOP Comparison
KNRX vs FBIOP Comparison
Compare KNRX & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNRX
- FBIOP
- Stock Information
- Founded
- KNRX 2009
- FBIOP N/A
- Country
- KNRX Singapore
- FBIOP United States
- Employees
- KNRX N/A
- FBIOP 101
- Industry
- KNRX Computer Software: Programming Data Processing
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- KNRX Technology
- FBIOP Health Care
- Exchange
- KNRX Nasdaq
- FBIOP Nasdaq
- Market Cap
- KNRX N/A
- FBIOP N/A
- IPO Year
- KNRX 2025
- FBIOP N/A
- Fundamental
- Price
- KNRX $2.06
- FBIOP $6.82
- Analyst Decision
- KNRX
- FBIOP
- Analyst Count
- KNRX 0
- FBIOP 0
- Target Price
- KNRX N/A
- FBIOP N/A
- AVG Volume (30 Days)
- KNRX 124.1K
- FBIOP N/A
- Earning Date
- KNRX 11-06-2025
- FBIOP N/A
- Dividend Yield
- KNRX N/A
- FBIOP N/A
- EPS Growth
- KNRX N/A
- FBIOP N/A
- EPS
- KNRX N/A
- FBIOP N/A
- Revenue
- KNRX $10,820,365.00
- FBIOP N/A
- Revenue This Year
- KNRX N/A
- FBIOP N/A
- Revenue Next Year
- KNRX N/A
- FBIOP N/A
- P/E Ratio
- KNRX N/A
- FBIOP N/A
- Revenue Growth
- KNRX 24.00
- FBIOP N/A
- 52 Week Low
- KNRX $1.75
- FBIOP N/A
- 52 Week High
- KNRX $4.00
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- KNRX N/A
- FBIOP 31.48
- Support Level
- KNRX N/A
- FBIOP $6.71
- Resistance Level
- KNRX N/A
- FBIOP $7.07
- Average True Range (ATR)
- KNRX 0.00
- FBIOP 0.34
- MACD
- KNRX 0.00
- FBIOP -0.10
- Stochastic Oscillator
- KNRX 0.00
- FBIOP 16.95
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.